Kanchan Mukherjee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kanchan Mukherjee has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Mamta Verma
Ph.D. Scholar, Tata Institute of Social Sciences, Mumbai, Maharashtra
2 shared publicationsTom Walley
Institute of Psychology, Health, and Society, University of Liverpool, Liverpool, United Kingdom
2 shared publications- Uma Jadhav
School of Health System Studies, Tata Institute of Social Sciences, Mumbai, India
2 shared publications Akashdeep Singh Chauhan
Department of Community Medicine, School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, India
1 shared publicationAlan Haycox
1 shared publicationAnil Lalwani
1 shared publication
Latest Publications
- Open Access
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Awareness, Utilisation, and Financial Risk Protection under Ayushman Bharat-PMJAY scheme: A Cross-Sectional Study among Eligible Rural Households in Nawada District, Bihar, India
Background: The Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), which started in September 2018 is a publicly financed government healthcare scheme in India targeting the poor and marginalised population (around 500 million). The scheme gives the beneficiaries up to USD 5223 per year for hospital stays. The state of Bihar located in the north of India has a significant poor population but evidence suggests that the utilisation of the scheme is limited in this state. Hence, this study was conducted in one of the poorest districts in Bihar (Nawada district). Methods: This was a cross-sectional study using mixed methods to understand the implementation of the AB-PMJAY scheme in seven villages in two areas of Nawada district. The quantitative study included 130 families who faced hospitalisation and were eligible beneficiaries of the scheme. The qualitative part of the study included In-depth Interviews (IDIs) with 20 eligible beneficiaries. Results: Although the scheme has been running for over seven years, awareness and utilisation of the scheme was low. Only about 50% of the families who are eligible for the scheme have the card to access the free services. Also, some people who had the card and went to an empaneled hospital, were refused treatment. Although direct costs were minimal among those who availed the scheme, indirect costs like traveling, boarding and food were significant and contributed to catastrophic health expenditures. Conclusions : The effectiveness of AB-PMJAY is affected by poor awareness, hospital denial, lack of treatment with dignity, informal payments and non-existing facilitators within the hospital system.
- 29 July 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAwareness, Utilisation, and Financial Risk Protection under Ayushman Bharat-PMJAY scheme: A Cross-Sectional Study among Eligible Rural Households in Nawada District, Bihar, India
Background: The Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), which started in September 2018 is a publicly financed government healthcare scheme in India targeting the poor and marginalised population (around 500 million). The scheme gives the beneficiaries up to USD 5223 per year for hospital stays. The state of Bihar located in the north of India has a significant poor population but evidence suggests that the utilisation of the scheme is limited in this state. Hence, this study was conducted in one of the poorest districts in Bihar (Nawada district). Methods: This was a cross-sectional study using mixed methods to understand the implementation of the AB-PMJAY scheme in seven villages in two areas of Nawada district. The quantitative study included 130 families who faced hospitalisation and were eligible beneficiaries of the scheme. The qualitative part of the study included In-depth Interviews (IDIs) with 20 eligible beneficiaries. Results: Although the scheme has been running for over seven years, awareness and utilisation of the scheme was low. Only about 50% of the families who are eligible for the scheme have the card to access the free services. Also, some people who had the card and went to an empaneled hospital, were refused treatment. Although direct costs were minimal among those who availed the scheme, indirect costs like traveling, boarding and food were significant and contributed to catastrophic health expenditures. Conclusions : The effectiveness of AB-PMJAY is affected by poor awareness, hospital denial, lack of treatment with dignity, informal payments and non-existing facilitators within the hospital system.
- 8 August 2024
- Published by Springer Nature
- p. 249-269
Framework for Assessing the Value of Healthcare Innovations in India for Universal Health Coverage
- 8 August 2024
- Published by Springer Nature
- p. 249-269
Framework for Assessing the Value of Healthcare Innovations in India for Universal Health Coverage
- Open Access
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Innovations in Critical Care Management and Universal Health Coverage in India
Background Critical care management in healthcare is a lifesaving intervention that has evolved over time. Initially confined to hospitals, its role expanded to include home-based management, remote monitoring, artificial intelligence (AI) and smart wearables. The COVID-19 pandemic brought a focus on this critical sector in healthcare, and many innovations emerged to address the shortages in critical healthcare. However, there has been no systematic study on the type or nature of innovative products or services in this sector and their usefulness for Universal Health Coverage (UHC) in the Indian context. Also, the interaction of these innovations with the Indian innovation ecosystem has not been studied. Given the above knowledge gaps, this study explores innovations in this sector and their interactions with the Indian ecosystem. Objectives The study had the following objectives: 1. To identify critical healthcare innovations as per the operational criteria. 2. To explore the interactions of these innovations with the Indian ecosystem. 3. To understand the congruence of these innovations towards Universal Health Coverage (UHC) in India. Methods Innovations in critical healthcare were identified through a deductive approach using the criteria identified by Länsisalmi et al. UHC's value domains and dimensions were operationalised based on the World Health Organization (WHO) framework for UHC. Secondary data (academic journals, grey literature, social media, business reports, startup portals, and company websites) was analysed along with primary data collected through in-depth interviews with Key Informants. Data analysis was conducted through primary and secondary data triangulation, and the findings are described below. Results Eleven innovations were identified in this study covering the spectrum of medical devices (ventilators, defibrillators, AI-enabled remote patient monitoring devices, airway pressure devices, non-invasive vitals measuring devices), AI (cloud-based diagnostic platform and tele-ICU). Most of these innovations were incremental, and all were frugal in nature. Also, all innovations addressed the population health value and quality dimension of UHC. However, currently, they have limitations in addressing the availability, accessibility and affordability dimensions of UHC. The study recommends that policymakers in the state and federal government help facilitate the adoption of these critical care innovations in the public health care system towards achieving the goal of UHC.
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Open AccessInnovations in Critical Care Management and Universal Health Coverage in India
Background Critical care management in healthcare is a lifesaving intervention that has evolved over time. Initially confined to hospitals, its role expanded to include home-based management, remote monitoring, artificial intelligence (AI) and smart wearables. The COVID-19 pandemic brought a focus on this critical sector in healthcare, and many innovations emerged to address the shortages in critical healthcare. However, there has been no systematic study on the type or nature of innovative products or services in this sector and their usefulness for Universal Health Coverage (UHC) in the Indian context. Also, the interaction of these innovations with the Indian innovation ecosystem has not been studied. Given the above knowledge gaps, this study explores innovations in this sector and their interactions with the Indian ecosystem. Objectives The study had the following objectives: 1. To identify critical healthcare innovations as per the operational criteria. 2. To explore the interactions of these innovations with the Indian ecosystem. 3. To understand the congruence of these innovations towards Universal Health Coverage (UHC) in India. Methods Innovations in critical healthcare were identified through a deductive approach using the criteria identified by Länsisalmi et al. UHC's value domains and dimensions were operationalised based on the World Health Organization (WHO) framework for UHC. Secondary data (academic journals, grey literature, social media, business reports, startup portals, and company websites) was analysed along with primary data collected through in-depth interviews with Key Informants. Data analysis was conducted through primary and secondary data triangulation, and the findings are described below. Results Eleven innovations were identified in this study covering the spectrum of medical devices (ventilators, defibrillators, AI-enabled remote patient monitoring devices, airway pressure devices, non-invasive vitals measuring devices), AI (cloud-based diagnostic platform and tele-ICU). Most of these innovations were incremental, and all were frugal in nature. Also, all innovations addressed the population health value and quality dimension of UHC. However, currently, they have limitations in addressing the availability, accessibility and affordability dimensions of UHC. The study recommends that policymakers in the state and federal government help facilitate the adoption of these critical care innovations in the public health care system towards achieving the goal of UHC.
- Open Access
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Innovations in Alternative Medicine in India and Access to Healthcare
From the Alma Ata declaration in 1978 to the Sustainable Development Goals (SDGs) in 2015, health and healthcare have been a major policy focus worldwide. The concept of healthcare for all has evolved into Universal Health Coverage (UHC), which is part of goal three of the Sustainable Development Goals (SDGs). One key gap towards achieving UHC is access to essential healthcare services. The World Health Organisation (WHO) acknowledges the role of alternative medicines in addressing the gap in access to essential healthcare services. Accordingly, healthcare systems in different countries have evolved to include alternative medicines to achieve the goal of UHC. In India, alternative medicine mainly consists of the stream called AYUSH (Ayurveda, Unani, Yoga, Naturopathy, Siddha, and Homoeopathy) and is a part of the Indian healthcare system. However, gaps remain between the actual and potential performance of healthcare systems. One of the strategies for addressing the gaps has been innovations in healthcare. The Indian government, through its policy initiatives, is encouraging innovative startups, and in the Indian startup ecosystem, the health and wellness segment of startups (which includes alternative medicine) has evolved to address access to healthcare through innovations. Given the importance of access to healthcare services in UHC, it is important to understand this non-clinical dimension for alternative medicine startups. However, there has been no systematic study to explore the services of these innovative alternative medicine startups and their role in access to healthcare. In this context, this study was conducted with the following objectives: 1. To identify the key non-clinical innovations among the alternative medicine startups. 2. To understand the role of these innovations towards addressing access to healthcare. This study used a modified version of Levesque’s framework to understand patient-centred access to healthcare from the supply-side perspective. This modified framework included four dimensions for analysis- Approachability, Acceptability, Availability, and Affordability. The study was qualitative in nature and involved analysis of both primary (interviews of founders of the innovative startups) and secondary data (academic, grey literature, social media, news reports and business reports). Data triangulation from the primary and secondary data sources was conducted to arrive at the findings. Analysis of the 16 innovations identified in this study suggests that alternative medicine startups/companies have used technology as a medium of innovation. The use of technology included the creation of web-based platforms, digital apps, artificial intelligence (AI) and the use of online platforms to sell their products. Digital technology helped to improve the approachability dimension of access to alternative medicine to populations. However, access to digital technology is dependent on infrastructure like power supply, internet connectivity, and penetration of smartphones, which affects the availability dimension of these digital-centric innovations. This makes access to quality-controlled alternative medicine urban-centric. Digital mode of accessing alternative medicine would reduce indirect costs associated with travel time and loss of wages. However, the direct costs associated with accessing these services are dependent on individuals' ability to pay and may negatively affect the affordability dimension. Traditionally, alternative medicines are part of Indian culture and society. Hence, this improves the acceptability dimension of access to healthcare. However, the preference for face-to-face consultations and lower trust in digital interactions in the population negatively affect the acceptability and access to online healthcare consultations. The study recommends that in the current context, there needs to be a mix of digital and non-digital innovations to address the gaps in access to alternative medicine.
- 1 January 2024
- Published by Elsevier in SSRN Electronic Journal
Open AccessInnovations in Alternative Medicine in India and Access to Healthcare
From the Alma Ata declaration in 1978 to the Sustainable Development Goals (SDGs) in 2015, health and healthcare have been a major policy focus worldwide. The concept of healthcare for all has evolved into Universal Health Coverage (UHC), which is part of goal three of the Sustainable Development Goals (SDGs). One key gap towards achieving UHC is access to essential healthcare services. The World Health Organisation (WHO) acknowledges the role of alternative medicines in addressing the gap in access to essential healthcare services. Accordingly, healthcare systems in different countries have evolved to include alternative medicines to achieve the goal of UHC. In India, alternative medicine mainly consists of the stream called AYUSH (Ayurveda, Unani, Yoga, Naturopathy, Siddha, and Homoeopathy) and is a part of the Indian healthcare system. However, gaps remain between the actual and potential performance of healthcare systems. One of the strategies for addressing the gaps has been innovations in healthcare. The Indian government, through its policy initiatives, is encouraging innovative startups, and in the Indian startup ecosystem, the health and wellness segment of startups (which includes alternative medicine) has evolved to address access to healthcare through innovations. Given the importance of access to healthcare services in UHC, it is important to understand this non-clinical dimension for alternative medicine startups. However, there has been no systematic study to explore the services of these innovative alternative medicine startups and their role in access to healthcare. In this context, this study was conducted with the following objectives: 1. To identify the key non-clinical innovations among the alternative medicine startups. 2. To understand the role of these innovations towards addressing access to healthcare. This study used a modified version of Levesque’s framework to understand patient-centred access to healthcare from the supply-side perspective. This modified framework included four dimensions for analysis- Approachability, Acceptability, Availability, and Affordability. The study was qualitative in nature and involved analysis of both primary (interviews of founders of the innovative startups) and secondary data (academic, grey literature, social media, news reports and business reports). Data triangulation from the primary and secondary data sources was conducted to arrive at the findings. Analysis of the 16 innovations identified in this study suggests that alternative medicine startups/companies have used technology as a medium of innovation. The use of technology included the creation of web-based platforms, digital apps, artificial intelligence (AI) and the use of online platforms to sell their products. Digital technology helped to improve the approachability dimension of access to alternative medicine to populations. However, access to digital technology is dependent on infrastructure like power supply, internet connectivity, and penetration of smartphones, which affects the availability dimension of these digital-centric innovations. This makes access to quality-controlled alternative medicine urban-centric. Digital mode of accessing alternative medicine would reduce indirect costs associated with travel time and loss of wages. However, the direct costs associated with accessing these services are dependent on individuals' ability to pay and may negatively affect the affordability dimension. Traditionally, alternative medicines are part of Indian culture and society. Hence, this improves the acceptability dimension of access to healthcare. However, the preference for face-to-face consultations and lower trust in digital interactions in the population negatively affect the acceptability and access to online healthcare consultations. The study recommends that in the current context, there needs to be a mix of digital and non-digital innovations to address the gaps in access to alternative medicine.
- Open Access
- 7 June 2023
- Published by Elsevier in SSRN Electronic Journal
A Framework for Comparing Healthcare Innovation Diffusion from India
The Indian innovation ecosystem is a vibrant space, and India has emerged as the world's third-largest startup economy. Biotechnology, Digital healthcare and Medical devices have emerged as three key sectors in the innovation ecosystem of India. However, there has been no systematic understanding of the evolution and application of healthcare innovations in these sectors and its role in the Indian health systems. This study addresses this gap and aims at understanding the existing nature and scope of these innovations in India and creating an innovation diffusion framework based on the empirical findings. The application of innovation in biotechnology sector has resulted in many frugal applications, which have global applicability. Digital innovations have contributed to convenience in access to healthcare and medicines. However, their impact is dependent on supporting infrastructure and digital literacy. Innovations in medical devices have had a significant increase since the launch of the Startup India policy and during COVID-19 pandemic. However, further research is required to assess the impact of these healthcare innovations towards Universal Health Coverage.
- 7 June 2023
- Published by Elsevier in SSRN Electronic Journal
Open AccessA Framework for Comparing Healthcare Innovation Diffusion from India
The Indian innovation ecosystem is a vibrant space, and India has emerged as the world's third-largest startup economy. Biotechnology, Digital healthcare and Medical devices have emerged as three key sectors in the innovation ecosystem of India. However, there has been no systematic understanding of the evolution and application of healthcare innovations in these sectors and its role in the Indian health systems. This study addresses this gap and aims at understanding the existing nature and scope of these innovations in India and creating an innovation diffusion framework based on the empirical findings. The application of innovation in biotechnology sector has resulted in many frugal applications, which have global applicability. Digital innovations have contributed to convenience in access to healthcare and medicines. However, their impact is dependent on supporting infrastructure and digital literacy. Innovations in medical devices have had a significant increase since the launch of the Startup India policy and during COVID-19 pandemic. However, further research is required to assess the impact of these healthcare innovations towards Universal Health Coverage.
- 13 May 2022
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 38 (1) , 1-17
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”
There has been tremendous technological innovation in the healthcare sector, but it has also raised serious ethical and social concerns. The COVID-19 pandemic has only magnified these existing challenges. Hence, addressing these challenges becomes imperative in the “new normal.” In this context, this article uses a narrative synthesis approach to discuss the linkages of health technology, innovation, and policy to identify the challenges of this complex interaction by applying the principles of pragmatism and historicity to the existing literature. Moreover, the existing scientific mechanisms in the form of health technology assessment (HTA) and responsible innovation in health (RIH) are described to address these challenges. Using inductive epistemology, the linkages between HTA and RIH within a health innovation ecosystem framework are discussed for the future application of an integrated approach to address societal challenges. The proposed integrated approach of HTA and RIH is a work in progress and conceptualized as transdisciplinary, flexible, and adaptive, which is expected to facilitate future discussion, research, and policy action.
- 13 May 2022
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 38 (1) , 1-17
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”
There has been tremendous technological innovation in the healthcare sector, but it has also raised serious ethical and social concerns. The COVID-19 pandemic has only magnified these existing challenges. Hence, addressing these challenges becomes imperative in the “new normal.” In this context, this article uses a narrative synthesis approach to discuss the linkages of health technology, innovation, and policy to identify the challenges of this complex interaction by applying the principles of pragmatism and historicity to the existing literature. Moreover, the existing scientific mechanisms in the form of health technology assessment (HTA) and responsible innovation in health (RIH) are described to address these challenges. Using inductive epistemology, the linkages between HTA and RIH within a health innovation ecosystem framework are discussed for the future application of an integrated approach to address societal challenges. The proposed integrated approach of HTA and RIH is a work in progress and conceptualized as transdisciplinary, flexible, and adaptive, which is expected to facilitate future discussion, research, and policy action.
- Open Access
- 1 January 2022
- Published by Wolters Kluwer Health in International Journal of Preventive Medicine
- Vol. 13 (1) , 75
SARS-CoV-2 Testing in India: Please Mind the Gaps
- 1 January 2022
- Published by Wolters Kluwer Health in International Journal of Preventive Medicine
- Vol. 13 (1) , 75
Open AccessSARS-CoV-2 Testing in India: Please Mind the Gaps
- Open Access
A Novel Indicator for COVID-19 Pandemic Assessment and Comparison
Introduction: In an increasingly globalized world, no country can remain immune to the effect of the COVID-19 pandemic. The pandemic has exposed the need for effective public health surveillance in the interest of global health security. However, current indicators are limited in doing a comparative intercountry assessment and comparison because of variation in testing rates and reporting standards. Hence, this study attempts at addressing this gap. Methods: The study proposes incremental change in cases per testing rate (ICTR) as an indicator for doing cross country comparison of the pandemic progress. The equation for calculating this indicator is explained in this study. This is followed by measuring its strength of association and predictive power for determining change in SARS-CoV-2 cases in five countries (USA, UK, India, Pakistan and Bangladesh). Results and discussion: ICTR was found to have a significantly higher strength of association and predictive power (than the existing indicator-test positivity rate) for determining change in cases over different time periods. Using ICTR, cross country comparison was done for the five countries for15 months to draw deeper insights into the progress of the pandemic. Conclusions: The study finds ICTR to be a suitable indicator for intercountry comparison and intracountry monitoring of the pandemic, which would be useful for global COVID-19 surveillance.
Open AccessA Novel Indicator for COVID-19 Pandemic Assessment and Comparison
Introduction: In an increasingly globalized world, no country can remain immune to the effect of the COVID-19 pandemic. The pandemic has exposed the need for effective public health surveillance in the interest of global health security. However, current indicators are limited in doing a comparative intercountry assessment and comparison because of variation in testing rates and reporting standards. Hence, this study attempts at addressing this gap. Methods: The study proposes incremental change in cases per testing rate (ICTR) as an indicator for doing cross country comparison of the pandemic progress. The equation for calculating this indicator is explained in this study. This is followed by measuring its strength of association and predictive power for determining change in SARS-CoV-2 cases in five countries (USA, UK, India, Pakistan and Bangladesh). Results and discussion: ICTR was found to have a significantly higher strength of association and predictive power (than the existing indicator-test positivity rate) for determining change in cases over different time periods. Using ICTR, cross country comparison was done for the five countries for15 months to draw deeper insights into the progress of the pandemic. Conclusions: The study finds ICTR to be a suitable indicator for intercountry comparison and intracountry monitoring of the pandemic, which would be useful for global COVID-19 surveillance.
- Open Access
Federal Vaccine Policy and Interstate Variation in COVID-19 Vaccine Coverage in India
Introduction: On August 13, 2021, India completed 30 weeks of vaccination against COVID-19 for its eligible citizens. While the vaccination has made progress, there has been no study analyzing the federal/union vaccine policy and its effect on vaccination coverage across Indian states. In this context, this study analyses the federal vaccination policy and its effect on interstate variation in vaccine coverage and the correlation of state economy with vaccination coverage. Methods: The study analyses vaccine policy documents, secondary data on vaccination coverage and state gross domestic product (GDP) available in public domain. ANOVA test has been used to assess the effect of vaccine policy on interstate vaccine coverage and correlation-regression analysis has been conducted to assess the type and strength of association between gross state domestic product and vaccination coverage. Results: Interstate variation in vaccination coverage in the first 15 weeks was the least (F=3.5), when vaccine procurement and supply was entirely provided by the union/federal government and vaccination was limited to priority groups. However, with the extension of vaccine policy to other groups and reduction in federal government involvement in vaccine procurement, the interstate variation in vaccination coverage increased significantly (F=10.74) by the end of 30 weeks. The highest interstate variation was observed in the period between 23-30 weeks (F=25.31). State GDP was positively and strongly correlated with state vaccination coverage with a high coefficient of correlation (R=0.94) and high coefficient of determination (R 2 = 0.88). Conclusions: The study finds that federal procurement and supply of vaccination among prioritized groups has been the best strategy till date to address the inequity in vaccination coverage across the states of India.
Open AccessFederal Vaccine Policy and Interstate Variation in COVID-19 Vaccine Coverage in India
Introduction: On August 13, 2021, India completed 30 weeks of vaccination against COVID-19 for its eligible citizens. While the vaccination has made progress, there has been no study analyzing the federal/union vaccine policy and its effect on vaccination coverage across Indian states. In this context, this study analyses the federal vaccination policy and its effect on interstate variation in vaccine coverage and the correlation of state economy with vaccination coverage. Methods: The study analyses vaccine policy documents, secondary data on vaccination coverage and state gross domestic product (GDP) available in public domain. ANOVA test has been used to assess the effect of vaccine policy on interstate vaccine coverage and correlation-regression analysis has been conducted to assess the type and strength of association between gross state domestic product and vaccination coverage. Results: Interstate variation in vaccination coverage in the first 15 weeks was the least (F=3.5), when vaccine procurement and supply was entirely provided by the union/federal government and vaccination was limited to priority groups. However, with the extension of vaccine policy to other groups and reduction in federal government involvement in vaccine procurement, the interstate variation in vaccination coverage increased significantly (F=10.74) by the end of 30 weeks. The highest interstate variation was observed in the period between 23-30 weeks (F=25.31). State GDP was positively and strongly correlated with state vaccination coverage with a high coefficient of correlation (R=0.94) and high coefficient of determination (R 2 = 0.88). Conclusions: The study finds that federal procurement and supply of vaccination among prioritized groups has been the best strategy till date to address the inequity in vaccination coverage across the states of India.
- Open Access
- 28 June 2021
- Published by Cambridge University Press (CUP) in Cambridge Open Engage
Healthcare Innovations and Ecosystems: COVID-19 and Beyond
This presentation gives an overview of the healthcare sector innovations and ecosystems in the Indian context. It introduces the concept of health, healthcare and healthcare innovation which is followed by the concept of innovation life cycle and ecosystem. The presentation shares the pre-COVID-19 and current situation in India in the context of healthcare innovations and ecosystems. It provides insights on the role of Health Technology Assessment (HTA) in health innovation ecosystems and the contribution of academic research institutes like the Tata Institute of Social Sciences (TISS) in HTA for healthcare innovation. The presentation concludes by acknowledging that the COVID-19 innovation sprint has now become a marathon, and hence healthcare innovations addressing systemic long term implications like equity and sustainability of healthcare systems become critical in the 'new normal' emerging from this pandemic. COVID-19 although a 'destructive creation' provides an opportunity for 'creative destruction' of voids for a sustainable inclusive future.
- 28 June 2021
- Published by Cambridge University Press (CUP) in Cambridge Open Engage
Open AccessHealthcare Innovations and Ecosystems: COVID-19 and Beyond
This presentation gives an overview of the healthcare sector innovations and ecosystems in the Indian context. It introduces the concept of health, healthcare and healthcare innovation which is followed by the concept of innovation life cycle and ecosystem. The presentation shares the pre-COVID-19 and current situation in India in the context of healthcare innovations and ecosystems. It provides insights on the role of Health Technology Assessment (HTA) in health innovation ecosystems and the contribution of academic research institutes like the Tata Institute of Social Sciences (TISS) in HTA for healthcare innovation. The presentation concludes by acknowledging that the COVID-19 innovation sprint has now become a marathon, and hence healthcare innovations addressing systemic long term implications like equity and sustainability of healthcare systems become critical in the 'new normal' emerging from this pandemic. COVID-19 although a 'destructive creation' provides an opportunity for 'creative destruction' of voids for a sustainable inclusive future.